These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18781526)

  • 1. Poly-k-trend tests for survival adjusted analysis of tumor rates formulated as approximate multiple contrast test.
    Schaarschmidt F; Sill M; Hothorn LA
    J Biopharm Stat; 2008; 18(5):934-48. PubMed ID: 18781526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of false positive rates of peto and poly-3 methods for long-term carcinogenicity data analysis using multiple comparison adjustment method suggested by Lin and Rahman.
    Rahman MA; Lin KK
    J Biopharm Stat; 2008; 18(5):949-58. PubMed ID: 18781527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of k for the poly-k test with application to animal carcinogenicity studies.
    Moon H; Ahn H; Kodell RL; Lee JJ
    Stat Med; 2003 Aug; 22(16):2619-36. PubMed ID: 12898548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity.
    Bieler GS; Williams RL
    Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An age-adjusted bootstrap-based Poly-k test.
    Moon H; Ahn H; Kodell RL
    Stat Med; 2005 Apr; 24(8):1233-44. PubMed ID: 15573413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approximate simultaneous confidence intervals for multiple contrasts of binomial proportions.
    Schaarschmidt F; Sill M; Hothorn LA
    Biom J; 2008 Oct; 50(5):782-92. PubMed ID: 18932137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response test via closed-form solutions for constrained MLEs in survival/sacrifice experiments.
    Kim W; Ahn H; Moon H
    Stat Med; 2007 Feb; 26(3):694-708. PubMed ID: 16596576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of incidence rates in pre-clinical studies using a Williams-type procedure.
    Hothorn LA; Sill M; Schaarschmidt F
    Int J Biostat; 2010; 6(1):Article 15. PubMed ID: 21969973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical evaluation of mortality in long-term carcinogenicity bioassays using a Williams-type procedure.
    Herberich E; Hothorn LA
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):26-34. PubMed ID: 22749913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess mortality in two-year rodent carcinogenicity studies.
    Roth A; Kadyszewski E; Geffray B; Paulissen J; Weaver RJ
    Toxicol Pathol; 2007 Dec; 35(7):1040-3. PubMed ID: 18098048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples.
    Bailer AJ; Portier CJ
    Biometrics; 1988 Jun; 44(2):417-31. PubMed ID: 3390507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Order-restricted dose-related trend tests.
    Mancuso JY; Ahn H; Chen JJ
    Stat Med; 2001 Aug; 20(15):2305-18. PubMed ID: 11468765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survival-adjusted quantal-response test for analysis of tumor incidence rates in animal carcinogenicity studies.
    Peddada SD; Kissling GE
    Environ Health Perspect; 2006 Apr; 114(4):537-41. PubMed ID: 16581542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global tests for analysis of multiple tumour data from animal carcinogenicity experiments.
    Chen JJ
    Stat Med; 1996 Jun; 15(11):1217-25. PubMed ID: 8804149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of hazard and proof of safety in toxicological studies using simultaneous confidence intervals for differences and ratios to control.
    Hothorn LA; Hasler M
    J Biopharm Stat; 2008; 18(5):915-33. PubMed ID: 18781525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparability of results of postnatal and long-term tests for carcinogenicity.
    Sýkora I; Vortel V
    Neoplasma; 1993; 40(5):321-7. PubMed ID: 8272162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs.
    Lin KK; Rahman MA
    J Biopharm Stat; 1998 Mar; 8(1):1-15; discussion 17-22. PubMed ID: 9547425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidence intervals and p-values for Williams' and other step-down multiple comparison tests against control.
    Channon EJ; McEntegart DJ
    J Biopharm Stat; 2001; 11(1-2):45-63. PubMed ID: 11459442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptotic simultaneous confidence intervals for many-to-one comparisons of binary proportions in randomized clinical trials.
    Schaarschmidt F; Biesheuvel E; Hothorn LA
    J Biopharm Stat; 2009; 19(2):292-310. PubMed ID: 19212881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.